comprehensive -WSS

comprehensive

author：focus 2025-10-04 05:09:23 - browse：6

Illustration oh researchers look up at a blister pill pac. Part of the blister pack is filled with pills, while the center shows a sketch of a brain. -- biotech coverage from STAT — Mike Reddy for STAT

One by one, the companies behind Zoloft, Prozac, and Paxil soured on psychiatry.

It was the early 2000s, and as America warmed to the sounds of Sisqó and Shakira, the world’s largest pharmaceutical firms were running out of ideas to treat mental illness. Their blockbuster treatments for depression and schizophrenia had reshaped society and made billions of dollars in the process, but the old cash cows were soon to go generic. Efforts to one-up the last generation of drugs mostly resulted in incremental changes to aging medicines. And when insurance companies balked at paying brand-name prices for extended-release generics, the money dried up and the industry moved out.

“The mindset of Big Pharma in those days was one pill for millions and millions of people,” said John LaMattina, who led Pfizer’s research division from 1999 to 2007. “Everyone was looking for the next Lipitor, and when that fizzled out, there was an exodus out of psychotherapeutic areas.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Intermittent fasting comes with a heart risk? Not so fast

WSS

How dance can help nurses traumatized by Covid

As digital health tech proliferates, a new institute aims to cut through hype

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

Google and Epic fight stronger regulation of AI in health care

Argenx readies a blockbuster opportunity with drug for autoimmune disease

Creating egg and sperm cells from stem cells raises ethical issues

hotspot

comprehensive

hotspot

Peter Hotez and the public health issue of online harassment

In early work, researchers turn to CRISPR to treat Alzheimer's

The high cost of giving birth even with insurance

Future doctors should be trained to promote social change

Sports medicine is finally prioritizing gender equality

Medicare to cover more brain scans for Alzheimer’s patients

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Plastic surgeons increase patient psychiatric screenings

Hepatitis C has a cure — but many Americans still lack access to it

Medicare to cover more brain scans for Alzheimer’s patients

focus

Startup Neumora takes a novel depression drug to Phase 3

Medicare has a new plan to address drug shortages

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

Orchard's therapy for neuron disease in children wins FDA approval

Doctors find melanoma drugs effective against rare brain cancer

AI can’t replace a physician’s gut feeling

focus

leisure time

hotspot

knowledge